Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Environ Pollut ; 115(3): 473-81, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11789927

RESUMO

To determine whether elevated CO2 reduces or exacerbates the detrimental effects of O3 on aspen (Populus tremuloides Michx.). aspen clones 216 and 271 (O3 tolerant), and 259 (O3 sensitive) were exposed to ambient levels of CO2 and O3 or elevated levels of CO2, O3, or CO2 + O3 in the FACTS II (Aspen FACE) experiment, and physiological and molecular responses were measured and compared. Clone 259. the most O3-sensitive clone, showed the greatest amount of visible foliar symptoms as well as significant decreases in chlorophyll, carotenoid, starch, and ribulose-1, 5-bisphosphate carboxylase/oxygenase (Rubisco) concentrations and transcription levels for the Rubisco small subunit. Generally, the constitutive (basic) transcript levels for phenylalanine ammonialyase (PAL) and chalcone synthase (CHS) and the average antioxidant activities were lower for the ozone sensitive clone 259 as compared to the more tolerant 216 and 271 clones. A significant decrease in chlorophyll a, b and total (a + b) concentrations in CO2, O3, and CO2 + O3 plants was observed for all clones. Carotenoid concentrations were also significantly lower in all clones; however. CHS transcript levels were not significantly affected, suggesting a possible degradation of carotenoid pigments in O3-stressed plants. Antioxidant activities and PAL and 1-aminocyclopropane-l-carboxylic acid (ACC)-oxidase transcript levels showed a general increase in all O3 treated clones, while remaining low in CO2 and CO2 + O3 plants (although not all differences were significant). Our results suggest that the ascorbate-glutathione and phenylpropanoid pathways were activated under ozone stress and suppressed during exposure to elevated CO2. Although CO2 + O2 treatment resulted in a slight reduction of O3-induced leaf injury, it did not appear to ameliorate all of the harmful affects of O3 and, in fact. may have contributed to an increase in chloroplast damage in all three aspen clones.


Assuntos
Poluentes Atmosféricos/farmacologia , Dióxido de Carbono/farmacologia , Ozônio/farmacologia , Folhas de Planta/efeitos dos fármacos , Salicaceae/efeitos dos fármacos , Antioxidantes/metabolismo , Ácido Ascórbico/metabolismo , Câmaras de Exposição Atmosférica , Carotenoides/metabolismo , Clorofila/metabolismo , Clonagem de Organismos , Interações Medicamentosas , Perfilação da Expressão Gênica , Glutationa/metabolismo , Fenilpropionatos/metabolismo , Fotossíntese/genética , Fotossíntese/fisiologia , Folhas de Planta/genética , Folhas de Planta/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Ribulose-Bifosfato Carboxilase/metabolismo , Salicaceae/genética , Salicaceae/metabolismo , Sensibilidade e Especificidade
2.
J Virol Methods ; 33(3): 345-53, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1723735

RESUMO

The outer envelope glycoprotein gp51 and the core protein p24 of bovine leukemia virus (BLV), were purified from culture media of FLK-BLV cells by a single-step procedure, using immunoaffinity chromatography based on monoclonal antibodies to the respective proteins. About 90% of the envelope glycoprotein in the culture medium was recovered as a highly purified product. Both purified protein (gp51 and p24) preparations, were found to be highly specific antigens by ELISA, and did not cross-react with sera raised against the other antigen. The conformational epitopes on the purified gp51 were preserved as judged by their reactions with the corresponding monoclonal antibodies. The p24 ELISA reacted only with sera from naturally infected animals and not with sera from animals immunized with an experimental gp51-iscom vaccine. The p24 antigen is therefore useful for discriminating between BLV-infected animals and those immunized with a gp51 subunit vaccine.


Assuntos
Cromatografia de Afinidade/métodos , Vírus da Leucemia Bovina/química , Proteínas do Envelope Viral/isolamento & purificação , Animais , Anticorpos Monoclonais , Western Blotting , Bovinos , Linhagem Celular , Ensaio de Imunoadsorção Enzimática , Epitopos , Vírus da Leucemia Bovina/imunologia , Leucemia Experimental/microbiologia , Testes de Neutralização , Sensibilidade e Especificidade , Vacinação , Proteínas do Envelope Viral/imunologia
3.
Arch Virol ; 120(3-4): 219-31, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1720302

RESUMO

It is proposed that the envelope glycoprotein, gp 51, is the protective antigen of bovine leukemia virus (BLV). An experimental iscom vaccine has been prepared from immunoaffinity purified gp 51. To overcome the problem of integrating a nonamphipathic protein, gp 51 was partially denatured at pH 2.4 before integration into the iscom. The recovery of gp 51 into the iscom was calculated to be 85%. The gp 51 incorporated into iscom retained its physicochemical properties and the neutralizing epitopes F, G and H were found to be intact. The iscom preparation was shown to induce a specific immune response to gp 51 after inoculation into mice and calves, as tested by ELISA and Western blotting. Sera from the immunized calves specifically inhibited the VSV-(BLV) pseudotypes. Thus the gp 51-iscom preparations appear to be highly immunogenic and to induce a gp 51 specific response.


Assuntos
Antígenos Virais/imunologia , ISCOMs/imunologia , Vírus da Leucemia Bovina/imunologia , Proteínas do Envelope Viral/imunologia , Vacinas Virais/imunologia , Animais , Anticorpos Antivirais/sangue , Western Blotting , Bovinos , Centrifugação com Gradiente de Concentração , Eletroforese em Gel de Poliacrilamida , Ensaio de Imunoadsorção Enzimática , Epitopos , ISCOMs/análise , Imunização , Camundongos , Microscopia Eletrônica , Microscopia Imunoeletrônica
4.
Acta Virol ; 34(3): 246-55, 1990 May.
Artigo em Inglês | MEDLINE | ID: mdl-1980398

RESUMO

A panel of newly isolated monoclonal antibodies (MoAbs) is described which are specific for bovine leukaemia virus (BLV) envelope protein gp51. Epitope mapping using competition antibody binding assays and binding studies with gp51-related fusion proteins and synthetic peptides show that they are directed against seven independent antigenic determinants. Four of them are unrelated to the epitopes described earlier (Bruck et al., 1982a). We define three binding regions for the MoAbs on the gp51 molecule. The region between amino acids 170 and 217 is highly immunogenic when the isolated protein is used for immunization, and seems to be inaccessible for immune recognition when gp51 is associated with the virus envelope as it occurs during natural BLV infection.


Assuntos
Antígenos Virais/imunologia , Epitopos Imunodominantes/análise , Vírus da Leucemia Bovina/imunologia , Vacinas Sintéticas/análise , Proteínas do Envelope Viral/imunologia , Animais , Anticorpos Monoclonais/imunologia , Ligação Competitiva , Bovinos , Células Cultivadas , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Recombinantes de Fusão/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA